10-hydroxycamptothecin has been researched along with amsacrine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, Q; Li, D; Li, J; Liu, M; Mo, X; Qi, X; Wang, Q; Wu, G; Yu, G; Zhu, T | 1 |
| Andersson, BS; Ling, YH; Nelson, JA | 1 |
2 other study(ies) available for 10-hydroxycamptothecin and amsacrine
| Article | Year |
|---|---|
Structure-based discovery of cytotoxic dimeric tetrahydroxanthones as potential topoisomerase I inhibitors from a marine-derived fungus.
Topics: Antineoplastic Agents; Aspergillus; Cell Cycle Checkpoints; Cell Line, Tumor; Dimerization; Drug Discovery; Drug Screening Assays, Antitumor; Fungi; Humans; Molecular Docking Simulation; Molecular Structure; Necrosis; Topoisomerase I Inhibitors; Xanthones | 2018 |
DNA topoisomerase I as a site of action for 10-hydroxycamptothecin in human promyelocytic leukemia cells.
Topics: Amsacrine; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Division; DNA Damage; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Drug Resistance; Enzyme Inhibitors; Etoposide; Humans; Leukemia, Promyelocytic, Acute; Mutation; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1990 |